Deliberation stage (n = 32) | Decision-making stage (n = 24) | p-Value | |
---|---|---|---|
Sex* | |||
Male | 11 (34%) | 7 (29%) | n.s.† |
Female | 21(66%) | 17 (71%) | |
Age (years)‡ | 66.53 ± 11.76 | 69.33 ± 6.22 | n.s.§ |
BMI (kg/m2)‡ | 24.82 ± 2.41 | 25.82 ± 1.93 | n.s.∥ |
Diabetes mellitus* | 2 (6%) | 4 (17%) | n.s.¶ |
Depression disorder* | 0 (0%) | 2 (8%) | n.s.¶ |
Angina | 0 (0%) | 0 (0%) | n.s |
Cerebrovascular accident | 4 (12.5%) | 0 (0%) | n.s.¶ |
Site of osteoarthritis (year)* | |||
Right | 19 (59%) | 14 (58%) | n.s.† |
Left | 13 (41%) | 10 (42%) | |
Bilaterality of lateral knee OA | 6 (18.8%) | 8 (33%) | n.s.† |
OA site of contralateral side of knee | |||
None | 26 (81.3%) | 13 (54%) | n.s.† |
Medial OA | 0 (0%) | 3 (11%) | |
Lateral OA | 6 (18.8%) | 8 (31%) | |
Duration of symptoms (months) | 46.94 ± 58.71 | 47.80 ± 75.86 | n.s.§ |
Follow-up period (years) | 3.73 ± 2.13 | 3.60 ± 2.55 | n.s.§ |
Ipsilateral side pain VAS‡ | 4.06 ± 1.87 | 5.79 ± 2.06 | 0.002§,** |
Contralateral side pain VAS‡ | 3.94 ± 1.32 | 4.33 ± 2.70 | n.s.§ |
Trauma history* | 11 (34%) | 4 (17%) | n.s.† |
Injection history* | 20 (63%) | 20 (83%) | n.s.† |
Meniscectomy history* | |||
None | 20 (63%) | 20 (83%) | n.s.† |
Ipsilateral | 8 (25%) | 3 (13%) | |
Contralateral | 4 (12%) | 1 (4%) | |
Range of knee motion (°)‡ | |||
Flexion contracture | 2.14 ± 3.93 | 5.24 ± 8.29 | n.s.§ |
Further flexion | 135.00 ± 4.08 | 123.10 ± 15.29 | 0.01§,** |